Selective cyclooxygenase-2 inhibitor ameliorates cholecystokinin-octapeptide-induced acute pancreatitis in rats

World Journal of Gastroenterology

Volumn 13, Issue 16, 2007, Pages 2298-2304

  Seo, Sang Wan ^a,b   Jung, Won Seok ^a,b   Piao, Tai Guang ^a   Hong, Seung Heon ^b   Yun, Ki Jung ^b   Park, Rae Kil ^b   Shin, Min Kyo ^a   Song, Ho Joon ^a   Park, Sung Joo ^a  

^a Wonkwang University   (South Korea)

^b Wonkwang University   (South Korea)

Author keywords

Acute pancreatitis; Cholecystokinin octapeptide; SC 236

Indexed keywords

4 [5 (4 CHLOROPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; AMYLASE; CHOLECYSTOKININ OCTAPEPTIDE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; DIMETHYL SULFOXIDE; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 72; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOPEROXIDASE; TRIACYLGLYCEROL LIPASE;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG MECHANISM; ENZYME ACTIVITY; GENE ACTIVATION; MALE; NONHUMAN; ORGAN WEIGHT; PANCREAS; PATHOGENESIS; RAT; TREATMENT OUTCOME; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; WISTAR RAT;

EID: 34249855319     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i16.2298     Document Type: Article

References (33)

1. Baron TH, Morgan DE. Acute necrotizing pancreatitis. N Engl J Med 1999; 340: 1412-1417
2. Bhatia M, Brady M, Zagorski J, Christmas SE, Campbell F, Neoptolemos JP, Slavin J. Treatment with neutralising antibody against cytokine induced neutrophil chemoattractant (CINC) protects rats against acute pancreatitis associated lung injury. Gut 2000; 47: 838-844
3. O'Konski MS, Pandol SJ. Effects of caerulein on the apical cytoskeleton of the pancreatic acinar cell. J Clin Invest 1990; 86: 1649-1657
4. Jungermann J, Lerch MM, Weidenbach H, Lutz MP, Kruger B, Adler G. Disassembly of rat pancreatic acinar cell cytoskeleton during supramaximal secretagogue stimulation. Am J Physiol 1995; 268: G328-G338
5. Lerch MM, Adler G. Experimental animal models of acute pancreatitis. Int J Pancreatol 1994; 15: 159-170
6. Steer ML. Early events in acute pancreatitis. Baillieres Best Pract Res Clin Gastroenterol 1999; 13: 213-225
7. Lerch MM, Gorelick FS. Early trypsinogen activation in acute pancreatitis. Med Clin North Am 2000; 84: 549-563, viii
8. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 1998; 175: 76-83
9. Schmedtje JF Jr, Ji YS, Liu WL, DuBois RN, Runge MS. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem 1997; 272: 601-608
10. Roberts PJ, Morgan K, Miller R, Hunter JO, Middleton SJ. Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease. Gut 2001; 48: 468-472
11. Ethridge RT, Chung DH, Slogoff M, Ehlers RA, Hellmich MR, Rajaraman S, Saito H, Uchida T, Evers BM. Cyclooxygenase-2 gene disruption attenuates the severity of acute pancreatitis and pancreatitis-associated lung injury. Gastroenterology 2002; 123: 1311-1322
12. Song AM, Bhagat L, Singh VP, Van Acker GG, Steer ML, Saluja AK. Inhibition of cyclooxygenase-2 ameliorates the severity of pancreatitis and associated lung injury. Am J Physiol Gastrointest Liver Physiol 2002; 283: G1166-G1174
13. Yamamoto K, Arakawa T, Ueda N, Yamamoto S. Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem 1995; 270: 31315-31320
14. Norman RJ, Wu R. The potential danger of COX-2 inhibitors. Fertil Steril 2004; 81: 493-494
15. Foral PA, Nystrom KK, Wilson AF, Christensen CM. Gastrointestinal-related adverse effects of COX-2 inhibitors. Drugs Today (Barc) 2003; 39: 939-948
16. Seo SW, Koo HN, An HJ, Kwon KB, Lim BC, Seo EA, Ryu DG, Moon G, Kim HY, Kim HM, Hong SH. Taraxacum officinale protects against cholecystokinin-induced acute pancreatitis in rats. World J Gastroenterol 2005; 11: 597-599
17. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
18. Dyer RB, Herzog NK. Immunodepletion EMSA: a novel method to identify proteins in a protein-DNA complex. Nucleic Acids Res 1995; 23: 3345-3346
19. Slogoff MI, Ethridge RT, Rajaraman S, Evers BM. COX-2 inhibition results in alterations in nuclear factor (NF)-kappaB activation but not cytokine production in acute pancreatitis. J Gastrointest Surg 2004; 8: 511-519
20. Panozzo MP, Basso D, Fabris C, Faggian D, Meggiato T, Plebani M, Del Favero G, Fogar P, Scalon P, Ferrara C. Diagnostic utility of a new monoclonal antibody pancreatic isoamylase assay in chronic pancreatic diseases. J Clin Chem Clin Biochem 1990; 28: 485-488
21. Panteghini M, Pagani F, Bonora R. Clinical and analytical evaluation of a continuous enzymatic method for measuring pancreatic lipase activity. Clin Chem 1993; 39: 304-308
22. Wagner AC, Weber H, Jonas L, Nizze H, Strowski M, Fiedler F, Printz H, Steffen H, Goke B. Hyperthermia induces heat shock protein expression and protection against cerulein-induced pancreatitis in rats. Gastroenterology 1996; 111: 1333-1342
23. Exley AR, Leese T, Holliday MP, Swann RA, Cohen J. Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut 1992; 33: 1126-1128
24. Gross V, Leser HG, Heinisch A, Scholmerich J. Inflammatory mediators and cytokines--new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterology 1993; 40: 522-530
25. Heath DI, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993; 34: 41-45
26. Rakonczay Z Jr, Duda E, Kaszaki J, Ivanyi B, Boros I, Lonovics J, Takacs T. The anti-inflammatory effect of methylprednisolone occurs down-stream of nuclear factor-kappaB DNA binding in acute pancreatitis. Eur J Pharmacol 2003; 464: 217-227
27. de Gregorio R, Iniguez MA, Fresno M, Alemany S. Cot kinase induces cycl o oxygen ase-2 expression in T cells through activation of the nuclear factor of activated T cells. J Biol Chem 2001; 276: 27003-27009
28. Koki AT, Leahy KM, Masferrer JL. Potential utility of COX-2 inhibitors in chemoprevention and chemotherapy. Expert Opin Investig Drugs 1999; 8: 1623-1638
29. Hida T, Kozaki K, Muramatsu H, Masuda A, Shimizu S, Mitsudomi T, Sugiura T, Ogawa M, Takahashi T. Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin Cancer Res 2000; 6: 2006-2011
30. You HJ, Morch CD, Chen J, Arendt-Nielsen L. Differential antinociceptive effects induced by a selective cyclooxygenase-2 inhibitor (SC-236) on dorsal horn neurons and spinal withdrawal reflexes in anesthetized spinal rats. Neuroscience 2003; 121: 459-472
31. Schafer C, Williams JA. Stress kinases and heat shock proteins in the pancreas: possible roles in normal function and disease. J Gastroenterol 2000; 35: 1-9
32. Strowski MZ, Sparmann G, Weber H, Fiedler F, Printz H, Jonas L, Goke B, Wagner AC. Caerulein pancreatitis increases mRNA but reduces protein levels of rat pancreatic heat shock proteins. Am J Physiol 1997; 273: G937-G945
33. Lane JS, Todd KE, Gloor B, Chandler CF, Kau AW, Ashley SW, Reber HA, McFadden DW. Platelet activating factor antagonism reduces the systemic inflammatory response in a murine model of acute pancreatitis. J Surg Res 2001; 99: 365-370